相关实验视频

Updated: Jun 12, 2025

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

转移性胰腺癌的全身疗法-当前景观和未来方向

Daniel Netto¹, Melissa Frizziero¹, Victoria Foy¹

¹The Christie NHS Foundation Trust, 550 Wilmslow Road, Manchester M20 4BX, UK.

Current oncology (Toronto, Ont.)

|September 27, 2024

概括

胰腺癌 (PDAC) 的治疗结果不佳,但新的治疗方法正在出现. 纳波利-3试验建议纳利里福克斯作为一线选择,而KRAS G12D抑制剂对这种常见突变显示出希望.

科学领域:

在瘤学瘤学.
胃肠病学胃肠病学
癌症研究癌症研究

背景情况:

胰腺管腺癌 (PDAC) 由于高死亡率和发病率的增加,对全球健康构成了重大挑战.
有限的预测性风险因素阻碍了有效的PDAC查计划.
过去的治疗依赖于化疗,因为缺乏可操作的突变和免疫抑制的瘤微环境.

研究的目的:

审查PDAC治疗策略的最新进展.
根据NAPOLI-3试验数据,强调纳利里福克斯作为一线治疗的潜力.
讨论KRAS突变的新兴向疗法和PDAC免疫治疗的未来.

主要方法:

对临床试验数据的审查,特别是NAPOLI-3试验.
对PDAC中普遍存在的基因突变的分析,重点是KRAS G12D.
评估当前和正在研究的治疗方法,包括化疗,向治疗和免疫治疗.

主要成果:

纳波利-3试验提供了NALIRIFOX作为PDAC潜在的新一线护理标准的证据.
在90%以上的PDAC病例中发现了KRAS G12D突变,开发小分子抑制剂显示出治疗潜力.
目前的免疫疗法表现出有限的成功,但与化疗或向药物的组合正在研究中.

结论:

纳利里福克斯代表了一项重大进展,可能成为PDAC的新一线治疗方法.
针对KRAS突变的向疗法,包括KRAS G12D,提供了新的希望,并正在临床试验中取得进展.
涉及化疗,向药物和免疫治疗的组合策略需要进一步的研究,以改善PDAC患者的治疗结果.

关键词:

克拉斯 (Kras) 是一个国家.化疗化疗是一种化学疗法.转移性转移性转移性分子造型分析 (MOP) 是一种分子造型分析.胰腺胰腺是什么

更多相关视频

Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer

Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer

Published on: October 4, 2022

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Chronic Pancreatitis II: Collaborative Care

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Metastasis

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...